Table III.
Variable | All patients | Comparative groups | Difference between groups, p | |
---|---|---|---|---|
SAGB | MiniMizer Extra | |||
IWL [kg] | 19.5 ±11.9 | 18.2 ±12 | 20.7 ±11.9 | 0.321 |
(–4.3-60) | (0-60) | (–4.3-54) | ||
IBMIL [kg/m2] | 6.7 ±3.9 | 6.2 ±3.9 | 7.1 ±4.0 | 0.259 |
(–1.4-19.9) | (0-18.1) | (–1.4-19.9) | ||
%IWL [%] | 14.4 ±8.5 | 12.9 ±8.1 | 15.7 ±8.7 | 0.112 |
(–2.6-37.9) | (0-35.4) | (–2.6-37.9) | ||
%IBMIL [%] | 14.4 ±8.5 | 12.9 ±8.1 | 15.7 ±8.7 | 0.112 |
(–2.6-37.9) | (0-35.4) | (–2.6-37.9) | ||
IFML [kg] | 12.3 ±7.6 | 10.7 ±6.9 | 13.5 ±7.9 | 0.090 |
(–0.7-37.7) | (–0.4-31.4) | (–0.7-37.7) | ||
IFMIL [kg/m2] | 4.3 ±2.7 | 3.7 ±2.4 | 4.71 ±2.8 | 0.094 |
(–0.2-14.7) | (–0.1-11.5) | (–0.2-14.7) | ||
%IFML [%] | 21.0 ±12.7 | 18.1 ±11.9 | 23.3 ±12.9 | 0.062 |
(–1.2-58.0) | (–0.7-58.0) | (–1.2-56.1) | ||
%IFMIL [%] | 21.0 ±12.7 | 18.1 ±11.9 | 23.3 ±12.9 | 0.062 |
(–1.2-58.0) | (–0.7-58.0) | (–1.2-56.1) | ||
%IEWL [%] | 33.1 ±21.9 | 28.9 ±21.3 | 36.8 ±22.1 | 0.075 |
(–4.9-124.1) | (0-124.1) | (–4.9-91.1) | ||
%IEBMIL [%] | 33.1 ±21.9 | 28.9 ±21.3 | 36.8 ±22.1 | 0.075 |
(–4.9-124.1) | (0-124.1) | (–4.9-91.1) | ||
IFML/IWL | 0.61 ±0.2 | 0.6 ±0.2 | 0.6 ±0.2 | 0.364 |
(–0.1-1.2) | (–0.1-1.1) | (0-1.2) |
IWL – initial body weight loss, %IWL – percentage of initial body weight loss, IBMIL – initial body mass index loss, %IBMIL – percentage of initial body mass index loss, IFML – initial fat mass loss, %IFML – percentage of initial fat mass loss, IFMIL – initial fat mass index loss, %IFMIL – percentage of initial fat mass index loss, %IEWL – percentage of initial excess weight loss, %IEBMIL – percentage of initial excess body mass index loss, IFML/IWL – initial fat mass loss and initial body weight loss ratio (shows proportion of fat mass loss in body weight loss). Data are given as mean ± SD (range)